Lxo Drug Patent Portfolio
Lxo owns 3 orange book drugs protected by 24 US patents Given below is the list of Lxo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11357753 | Rescue treatment of post operative nausea and vomiting | 09 Feb, 2038 | Active |
| US12005042 | Rescue treatment of post operative nausea and vomiting | 09 Feb, 2038 | Active |
| US12329740 | Rescue treatment of post operative nausea and vomiting | 09 Feb, 2038 | Active |
| US10016407 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10149843 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10231961 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10413505 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10420760 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10857095 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10894012 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10933060 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10973811 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10987347 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US11040032 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US9867815 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US9084765 | Use of amisulpride as an anti-emetic | 26 Feb, 2034 | Active |
| US10525033 | Use of amisulpride as an anti-emetic | 10 Mar, 2031 | Active |
| US12194022 | Use of amisulpride as an anti-emetic | 10 Mar, 2031 | Active |
| US9545426 | Use of amisulpride as an anti-emetic | 10 Mar, 2031 | Active |
| US9889118 | Use of amisulpride as an anti-emetic | 10 Mar, 2031 | Active |
| US8617595 | Galenic formulations of organic compounds | 19 Aug, 2026 | Active |
| US8617595 | Galenic formulations of organic compounds | 19 Feb, 2026 | Expired |
| US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides | 21 Jan, 2019 | Expired |
| US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides | 21 Jul, 2018 | Expired |
Latest Legal Activities on Lxo's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lxo.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 Dec, 2025 | US10016407 (Litigated) |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 15 Dec, 2025 | US11357753 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 13 Aug, 2025 | US9889118 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Jul, 2025 | US9867815 (Litigated) |
| Recordation of Patent Grant Mailed | 24 Jun, 2025 | US12329740 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Jun, 2025 | US8617595 |
| Recordation of Patent eGrant | 17 Jun, 2025 | US12329740 |
| Mail Patent eGrant Notification | 17 Jun, 2025 | US12329740 |
| Patent Issue Date Used in PTA Calculation | 17 Jun, 2025 | US12329740 |
| Email Notification | 17 Jun, 2025 | US12329740 |
| Patent eGrant Notification | 17 Jun, 2025 | US12329740 |
| Email Notification | 05 Jun, 2025 | US12329740 |
| Issue Notification Mailed | 04 Jun, 2025 | US12329740 |
| Dispatch to FDC | 21 May, 2025 | US12329740 |
| Application Is Considered Ready for Issue | 21 May, 2025 | US12329740 |
Lxo's Family Patents
Lxo drugs have patent protection in a total of 36 countries. It's US patent count contributes only to 27.3% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Lxo Drug List
Given below is the complete list of Lxo's drugs and the patents protecting them.
1. Barhemsys
Barhemsys is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11357753 | Rescue treatment of post operative nausea and vomiting |
09 Feb, 2038
(11 years from now)
| Active |
| US12005042 | Rescue treatment of post operative nausea and vomiting |
09 Feb, 2038
(11 years from now)
| Active |
| US12329740 | Rescue treatment of post operative nausea and vomiting |
09 Feb, 2038
(11 years from now)
| Active |
| US9084765 | Use of amisulpride as an anti-emetic |
26 Feb, 2034
(7 years from now)
| Active |
| US10525033 | Use of amisulpride as an anti-emetic |
10 Mar, 2031
(4 years from now)
| Active |
| US12194022 | Use of amisulpride as an anti-emetic |
10 Mar, 2031
(4 years from now)
| Active |
| US9545426 | Use of amisulpride as an anti-emetic |
10 Mar, 2031
(4 years from now)
| Active |
| US9889118 | Use of amisulpride as an anti-emetic |
10 Mar, 2031
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Barhemsys's drug page
2. Goprelto
Goprelto is protected by 12 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016407 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10149843 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10231961 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10413505 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10420760 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10857095 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10894012 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10933060 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10973811 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10987347 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US11040032 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US9867815 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Goprelto's drug page
3. Tekturna
Tekturna is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8617595
(Pediatric)
| Galenic formulations of organic compounds |
19 Aug, 2026
(a month from now)
| Active |
| US8617595 | Galenic formulations of organic compounds |
19 Feb, 2026
(4 months ago)
| Expired |
| US5559111
(Pediatric)
| δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
21 Jan, 2019
(7 years ago)
| Expired |
| US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
21 Jul, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tekturna's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List